These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29080666)

  • 1. Topically applied virus-like particles containing HIV-1 Pr55
    Rancan F; Afraz Z; Hadam S; Weiß L; Perrin H; Kliche A; Schrade P; Bachmann S; Schäfer-Korting M; Blume-Peytavi U; Wagner R; Combadière B; Vogt A
    J Control Release; 2017 Dec; 268():296-304. PubMed ID: 29080666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells.
    Rancan F; Amselgruber S; Hadam S; Munier S; Pavot V; Verrier B; Hackbarth S; Combadiere B; Blume-Peytavi U; Vogt A
    J Control Release; 2014 Feb; 176():115-22. PubMed ID: 24384300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair follicle targeting, penetration enhancement and Langerhans cell activation make cyanoacrylate skin surface stripping a promising delivery technique for transcutaneous immunization with large molecules and particle-based vaccines.
    Vogt A; Hadam S; Deckert I; Schmidt J; Stroux A; Afraz Z; Rancan F; Lademann J; Combadiere B; Blume-Peytavi U
    Exp Dermatol; 2015 Jan; 24(1):73-5. PubMed ID: 25382068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels.
    Rancan F; Giulbudagian M; Jurisch J; Blume-Peytavi U; Calderón M; Vogt A
    Eur J Pharm Biopharm; 2017 Jul; 116():4-11. PubMed ID: 27865989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological and Molecular Effects of in vivo and ex vivo Mild Skin Barrier Disruption.
    Pfannes EKB; Weiss L; Hadam S; Gonnet J; Combardière B; Blume-Peytavi U; Vogt A
    Skin Pharmacol Physiol; 2018; 31(3):115-124. PubMed ID: 29510378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers.
    Döge N; Hönzke S; Schumacher F; Balzus B; Colombo M; Hadam S; Rancan F; Blume-Peytavi U; Schäfer-Korting M; Schindler A; Rühl E; Skov PS; Church MK; Hedtrich S; Kleuser B; Bodmeier R; Vogt A
    J Control Release; 2016 Nov; 242():25-34. PubMed ID: 27394682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination.
    Mohsen MO; Gomes AC; Cabral-Miranda G; Krueger CC; Leoratti FM; Stein JV; Bachmann MF
    J Control Release; 2017 Apr; 251():92-100. PubMed ID: 28257987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prime-boost immunisation regimen using recombinant BCG and Pr55(gag) virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons.
    Chege GK; Thomas R; Shephard EG; Meyers A; Bourn W; Williamson C; Maclean J; Gray CM; Rybicki EP; Williamson AL
    Vaccine; 2009 Jul; 27(35):4857-66. PubMed ID: 19520196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.
    Mahe B; Vogt A; Liard C; Duffy D; Abadie V; Bonduelle O; Boissonnas A; Sterry W; Verrier B; Blume-Peytavi U; Combadiere B
    J Invest Dermatol; 2009 May; 129(5):1156-64. PubMed ID: 19052565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.
    Liao WH; Huang KJ; Chang YF; Wang SM; Tseng YT; Chiang CC; Wang JJ; Wang CT
    J Virol; 2007 May; 81(10):5155-65. PubMed ID: 17344306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin.
    Vogt A; Combadiere B; Hadam S; Stieler KM; Lademann J; Schaefer H; Autran B; Sterry W; Blume-Peytavi U
    J Invest Dermatol; 2006 Jun; 126(6):1316-22. PubMed ID: 16614727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle-based vaccines for transcutaneous vaccination.
    Combadière B; Mahé B
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):293-315. PubMed ID: 17915323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
    Inoue J; Aramaki Y
    Vaccine; 2007 Jan; 25(6):1007-13. PubMed ID: 17049678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.
    Pitoiset F; Vazquez T; Levacher B; Nehar-Belaid D; Dérian N; Vigneron J; Klatzmann D; Bellier B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
    Venereo-Sanchez A; Simoneau M; Lanthier S; Chahal P; Bourget L; Ansorge S; Gilbert R; Henry O; Kamen A
    Vaccine; 2017 Jul; 35(33):4220-4228. PubMed ID: 28648546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Outermost Stratum Corneum Layer is an Effective Barrier Against Dermal Uptake of Topically Applied Micronized Titanium Dioxide.
    Pflücker F; Hohenberg H; Hölzle E; Will T; Pfeiffer S; Wepf R; Diembeck W; Wenck H; Gers-Barlag H
    Int J Cosmet Sci; 1999 Dec; 21(6):399-411. PubMed ID: 18503454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.